This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corrales, M.
Right arrow Articles by Basombrío, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corrales, M.
Right arrow Articles by Basombrío, M. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2005, p. 1556-1560, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1556-1560.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Comparative Efficacies of TAK-187, a Long-Lasting Ergosterol Biosynthesis Inhibitor, and Benznidazole in Preventing Cardiac Damage in a Murine Model of Chagas' Disease

Milagros Corrales,1 Rubén Cardozo,1 María Asunción Segura,1 Julio A. Urbina,2* and Miguel Angel Basombrío1*

Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Buenos Aires, Salta, Argentina,1 Laboratorio de Quimica Biológica, Centro de Bioquimica y Biofisica, Instituto Venezolano de Investigaciones Cientificas, Carretera Panamericana, Caracas, Venezuela2

Received 23 October 2004/ Returned for modification 14 November 2004/ Accepted 14 December 2004

We carried out a comparative study of benznidazole and TAK-187, a long-lasting ergosterol biosynthesis inhibitor, with a murine model of Chagas' disease. The results indicated that TAK-187 was more effective than benznidazole in preventing Trypanosoma cruzi-induced cardiac damage in experimental animals.


* Corresponding author. Mailing address for Julio A. Urbina: Laboratorio de Quimica Biológica, Centro de Bioquimica y Biofisica, Instituto Venezolano de Investigaciones Cientificas, Altos de Pipe, Km. 11, Carretera Panamericana, Caracas 1020, Venezuela. Phone: (58-212)-5041660. Fax: (58-212)-5041093. E-mail: jaurbina{at}ivic.ve. Mailing address for Miguel Angel Basombrío: Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Buenos Aires 177, 4.400 Salta, Argentina. Phone: (54-387)-4255333. Fax: (54-387)-4255333. E-mail: basombri{at}unsa.edu.ar.

* Corresponding author. Mailing address for Julio A. Urbina: Laboratorio de Quimica Biológica, Centro de Bioquimica y Biofisica, Instituto Venezolano de Investigaciones Cientificas, Altos de Pipe, Km. 11, Carretera Panamericana, Caracas 1020, Venezuela. Phone: (58-212)-5041660. Fax: (58-212)-5041093. E-mail: jaurbina{at}ivic.ve. Mailing address for Miguel Angel Basombrío: Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Buenos Aires 177, 4.400 Salta, Argentina. Phone: (54-387)-4255333. Fax: (54-387)-4255333. E-mail: basombri{at}unsa.edu.ar.


Antimicrobial Agents and Chemotherapy, April 2005, p. 1556-1560, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1556-1560.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Rassi, A Jr, Dias, J C P, Marin-Neto, J A, Rassi, A (2009). Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart 95: 524-534 [Abstract] [Full Text]  
  • Martins, H. R., Figueiredo, L. M., Valamiel-Silva, J. C. O., Carneiro, C. M., Machado-Coelho, G. L. L., Vitelli-Avelar, D. M., Bahia, M. T., Martins-Filho, O. A., Macedo, A. M., Lana, M. (2008). Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes. J Antimicrob Chemother 61: 1319-1327 [Abstract] [Full Text]  
  • Hyland, K. V., Leon, J. S., Daniels, M. D., Giafis, N., Woods, L. M., Bahk, T. J., Wang, K., Engman, D. M. (2007). Modulation of Autoimmunity by Treatment of an Infectious Disease. Infect. Immun. 75: 3641-3650 [Abstract] [Full Text]  
  • Ferraz, M. L., Gazzinelli, R. T., Alves, R. O., Urbina, J. A., Romanha, A. J. (2007). The Anti-Trypanosoma cruzi Activity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of Benznidazole. Antimicrob. Agents Chemother. 51: 1359-1364 [Abstract] [Full Text]